PROGENICS PHARMACEUTICALS
Summary
Progenics Pharmaceuticals is an oncology company developing innovative medicines and artificial intelligence to find, fight and follow cancer.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 423 M
Avg. Deal Size£ 423 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
